Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Intervalo de año de publicación
1.
Arch Soc Esp Oftalmol (Engl Ed) ; 97(3): 168-171, 2022 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-35248399

RESUMEN

Primary central nervous system lymphoma is one of the most infrequent brain tumours, accounting for 3% of primary central nervous system neoplasms. In addition to its low prevalence, clinical presentation is usually nonspecific, leading to diagnostic delay. Intraocular involvement occurs in 15% of cases, and disease onset in this location is even rarer. We present a case of a patient with intermediate uveitis as the first clinical manifestation of this neoplasm.


Asunto(s)
Neoplasias Encefálicas , Linfoma , Uveítis , Neoplasias Encefálicas/diagnóstico por imagen , Sistema Nervioso Central/patología , Diagnóstico Tardío , Humanos , Linfoma/diagnóstico por imagen , Uveítis/diagnóstico
2.
Arch. Soc. Esp. Oftalmol ; 97(3): 168-171, mar. 2022. ilus
Artículo en Español | IBECS | ID: ibc-208835

RESUMEN

El linfoma primario del sistema nervioso central (LPSNC) es una de las neoplasias cerebrales más infrecuentes, representando el 3% de los tumores primarios en dicha localización. Sumado a su baja prevalencia, las manifestaciones clínicas de esta patología son poco específicas, por lo que es común el retraso diagnóstico de esta entidad. El compromiso intraocular relacionado al LPSNC ocurre sólo en un 15% de los casos, siendo aún más inusual que dicha topografía se presente como debut en esta enfermedad. Presentamos el caso clínico de una paciente con uveítis intermedia como primera manifestación clínica de esta neoplasia (AU)


Primary central nervous system lymphoma is one of the most infrequent brain tumours, accounting for 3% of primary central nervous system neoplasms. In addition to its low prevalence, clinical presentation is usually nonspecific, leading to diagnostic delay. Intraocular involvement occurs in 15% of cases, and disease onset in this location is even rarer. We present a case of a patient with intermediate uveitis as the first clinical manifestation of this neoplasm (AU)


Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Neoplasias del Sistema Nervioso Central/complicaciones , Neoplasias del Sistema Nervioso Central/diagnóstico por imagen , Uveítis Intermedia/diagnóstico por imagen , Uveítis Intermedia/etiología , Linfoma/diagnóstico por imagen , Linfoma/complicaciones , Tomografía de Coherencia Óptica , Diagnóstico Tardío
3.
Artículo en Inglés, Español | MEDLINE | ID: mdl-33640210

RESUMEN

Primary central nervous system lymphoma is one of the most infrequent brain tumours, accounting for 3% of primary central nervous system neoplasms. In addition to its low prevalence, clinical presentation is usually nonspecific, leading to diagnostic delay. Intraocular involvement occurs in 15% of cases, and disease onset in this location is even rarer. We present a case of a patient with intermediate uveitis as the first clinical manifestation of this neoplasm.

4.
Mult Scler Relat Disord ; 39: 101892, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31846866

RESUMEN

BACKGROUND: Although solid information on the natural history of primary progressive multiple sclerosis (PPMS) is available, evidence regarding impact of disease activity on PPMS progression remains controversial. OBJECTIVE: To describe the clinical characteristics, presence or absence of MRI activity, and natural history of a PPMS cohort from two referral centers in Argentina and assess whether clinical and/or radiological disease activity correlated with disability worsening. METHODS: Retrospective study conducted at two MS clinics in Buenos Aires, Argentina, through comparative analysis of patients with and without evidence of disease activity. RESULTS: Clinical and/or radiologic activity was presented in 56 (31%) of 178 patients. When stratified by age at onset, we found that for every 10 years of increase in age at onset, risk of reaching EDSS scores of 4 and 6 increased by 26% and 31%, respectively (EDSS 4: HR 1.26, CI 95%: 1.06-1.50; EDSS 6: HR 1.31, CI 95%: 1.06-1.62). Patients who presented clinical exacerbations reached EDSS scores of 6, 7 and 8 faster than those without associated exacerbations (p = 0.009, p = 0.016 and p = 0.001, respectively). Likewise, patients who presented gadolinium-enhancing lesions during the course of disease reached EDSS scores of 7 earlier (p = 0.002). CONCLUSION: Older age at onset and presence of clinical and/or radiological disease activity correlated with accelerated disability progression in this cohort of PPMS patients.

5.
Rev Neurol ; 69(7): 301-302, 2019 Oct 01.
Artículo en Español | MEDLINE | ID: mdl-31559629
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...